Post has attachment
Coronary Stent Market Chances To Reach $15.18 Billion By 2024

 Rising prevalence of coronary artery diseases, supportive government reforms and increasing awareness are contributing factors for lucrative growth of coronary stents

Know More :- https://tinyurl.com/ybzbhu4x
Photo

Post has attachment
Bioresorbable Stent Market Worth 417.2 Million USD by 2022

According to a new market research report "Bioabsorbable Stent/Bioresorbable Scaffold Market by Material (Polymer/Metal), Absorption Rate (Slow, Fast), Application (Coronary Artery Disease/CAD, Peripheral/PAD) & End User (Hospital, Cardiovascular Center) - Global Forecasts to 2022", published by MarketsandMarkets™, the global market is expected to reach USD 417.2 Million by 2022 from USD 223.6 Million in 2016, at a CAGR of 11.5% during the forecast period 2017-2022.

Browse 73 Market Data Tables and 33 Figures spread through 138 Slides and in-depth TOC on "Bioabsorbable Stent/Bioresorbable Scaffold Market"

http://www.marketsandmarkets.com/Market-Reports/bioabsorbable-stent-market-40983380.html
Early buyers will receive 10% customization on this report

The growth of the market is attributed to growing aging population susceptible to coronary and peripheral artery diseases, rising PCI procedures, increasing focus of companies on clinical trials of bioresorbable Stent, increasing adoption of these Stent by physicians and patients, and preference for minimally invasive therapies.

Bioresorbable polymer-based Stent projected to grow at the highest CAGR

Based on material, the market is segmented into bioresorbable polymer-based Stent and bioresorbable metallic Stent. The bioresorbable polymer-based Stent segment is expected to grow at the highest CAGR during the forecast period. The growth of this market is attributed to companies' increasing focus on developing polymeric Stent and approvals being granted for polymer-based Stent across various regions

Download PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=40983380

Based on applications, the coronary artery diseases are expected to dominate the market in 2017

Based on application, the market is segmented into coronary artery diseases and peripheral artery diseases. In 2017, coronary artery diseases accounted for the largest share of the market. The dominance of this segment is attributed to factors such as increasing aging population prone to coronary artery diseases and the adoption of unhealthy lifestyle habits leading to increased risk of these diseases.

Europe to dominate the market during the forecast period

In 2017, Europe is expected to account for the largest share of the market. The dominance of the European market is attributed to the factors such as increasing regulatory approvals for Stent which will facilitate their commercialization and rising research activities for development of bioresorbable Stent. In 2017, Asia is expected to hold the second largest share of this market.

Talk To Our Research Analysts: http://www.marketsandmarkets.com/speaktoanalyst.asp?id=40983380

Factors such as, increasing industrial development, rising disposable income, burgeoning aging population with changing lifestyle (which have increased the prevalence of CAD), and the higher prevalence of diabetes are important factors to fuel the market growth in this region.

The bioresorbable Stent screening market is a niche market with the presence of several emerging players and few big players. Prominent players in the Bioresorbable Stent Market include Abbott (U.S.), BIOTRONIK SE & Co. KG (Germany), REVA Medical, Inc. (U.S.), Elixir Medical Corporation (U.S.), and Kyoto Medical Planning Co., Ltd. (Japan).



About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
newsletter@marketsandmarkets.com

Post has attachment
Bioresorbable Stent Market Worth 417.2 Million USD by 2022

According to a new market research report "Bioabsorbable Stent/Bioresorbable Scaffold Market by Material (Polymer/Metal), Absorption Rate (Slow, Fast), Application (Coronary Artery Disease/CAD, Peripheral/PAD) & End User (Hospital, Cardiovascular Center) - Global Forecasts to 2022", published by MarketsandMarkets™, the global market is expected to reach USD 417.2 Million by 2022 from USD 223.6 Million in 2016, at a CAGR of 11.5% during the forecast period 2017-2022.

Browse 73 Market Data Tables and 33 Figures spread through 138 Slides and in-depth TOC on "Bioabsorbable Stent/Bioresorbable Scaffold Market"

http://www.marketsandmarkets.com/Market-Reports/bioabsorbable-stent-market-40983380.html
Early buyers will receive 10% customization on this report

The growth of the market is attributed to growing aging population susceptible to coronary and peripheral artery diseases, rising PCI procedures, increasing focus of companies on clinical trials of bioresorbable Stent, increasing adoption of these Stent by physicians and patients, and preference for minimally invasive therapies.

Bioresorbable polymer-based Stent projected to grow at the highest CAGR

Based on material, the market is segmented into bioresorbable polymer-based Stent and bioresorbable metallic Stent. The bioresorbable polymer-based Stent segment is expected to grow at the highest CAGR during the forecast period. The growth of this market is attributed to companies' increasing focus on developing polymeric Stent and approvals being granted for polymer-based Stent across various regions

Download PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=40983380

Based on applications, the coronary artery diseases are expected to dominate the market in 2017

Based on application, the market is segmented into coronary artery diseases and peripheral artery diseases. In 2017, coronary artery diseases accounted for the largest share of the market. The dominance of this segment is attributed to factors such as increasing aging population prone to coronary artery diseases and the adoption of unhealthy lifestyle habits leading to increased risk of these diseases.

Europe to dominate the market during the forecast period

In 2017, Europe is expected to account for the largest share of the market. The dominance of the European market is attributed to the factors such as increasing regulatory approvals for Stent which will facilitate their commercialization and rising research activities for development of bioresorbable Stent. In 2017, Asia is expected to hold the second largest share of this market.

Talk To Our Research Analysts: http://www.marketsandmarkets.com/speaktoanalyst.asp?id=40983380

Factors such as, increasing industrial development, rising disposable income, burgeoning aging population with changing lifestyle (which have increased the prevalence of CAD), and the higher prevalence of diabetes are important factors to fuel the market growth in this region.

The bioresorbable Stent screening market is a niche market with the presence of several emerging players and few big players. Prominent players in the Bioresorbable Stent Market include Abbott (U.S.), BIOTRONIK SE & Co. KG (Germany), REVA Medical, Inc. (U.S.), Elixir Medical Corporation (U.S.), and Kyoto Medical Planning Co., Ltd. (Japan).

Browse Related Reports:

Vascular Stent Market by Type (BMS, BVS, Drug Eluting), Product (Coronary, Peripheral, Carotid, Femoral, Aortic Aneurysm), Material [Metal (Stainless Steel, PtCr, Nitinol), Polymer], End User (Hospital, Cardiology Center, ASC)- Global Forecast to 2021

http://www.marketsandmarkets.com/Market-Reports/vascular-stent-market-199869009.html

Coronary Stent Market by Type (BMS, BVS, Drug Eluting), Mode of Delivery (Self, Balloon Expandable), Material (Metal (Stainless Steel, CoCr, PtCr, Nitinol), Polymer, Copolymer), & End User (Hospital, Cardiology Center, ASC) - Global Forecasts to 2021

http://www.marketsandmarkets.com/Market-Reports/coronary-stent-market-77411272.html

Interventional Cardiology & Peripheral Vascular Devices Market (Embolic Protection, Chronic Total Occlusion, Atherectomy, Thrombectomy, IVUS, Angiography Catheters, EVAR Stent Grafts, IVC Filters, Stent, Balloons, and Accessories) - Forecasts to 2019

http://www.marketsandmarkets.com/Market-Reports/minimally-invasive-interventional-cardiology-devices-market-548.html

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
newsletter@marketsandmarkets.com

Post has attachment

Post has attachment

Post has attachment

Post has attachment
Credihealth provided #Medical care company offers Non-invasive CT #Coronary Angiography Test at affordable cost at it's center located in #Chennai.

#angiographytestcost #costofangiography #angioplastycostinapollo
Photo

Post has attachment
Get Sample Copy of This Report @ https://bit.ly/2HZB6zy

Angioplasty Balloon Market is driven by increasing numbers of the patient suffering cardiovascular disorder. According to the Centers for Disease Control and Prevention (CDC) 2015, around 610,000 global individuals death cases were filed due to critical heart conditions, and approximately 8 million individuals were diagnosed with peripheral as well as coronary artery disease. Such high prevalence requiring cardiovascular care is anticipated to bolster the global angioplasty balloon market. Moreover, growing geriatric population, inactive lifestyle and growing stress level due to professional as well as personal issues have led to a swell in critical heart diseases boosting the global market growth. Furthermore, state-of-the-art healthcare infrastructure in developed countries such as U.S., U.K., Canada, technological advancement for the cardiovascular disease treatment and a high level of awareness among people regarding the various treatment options for cardiovascular disorders is affecting significantly the angioplasty balloons market in these regions. However, price clash due to increase in the number of market players is a major restraint hampering the market growth.
The need for angioplasty or other cardiovascular treatment is observed due to factors such as high cholesterol in a blood vessel, obesity, and poor diet. According to the World Health Organizations (WHO), cardiovascular ailments are the major cause of death followed by cancer. Cardiovascular diseases are the life-threatening illness in which the insufficient blood flow to artery may lead to cardiac arrest. Hence, a person experiencing such ailment should be treated with angioplasty process, which cleanses the blocked and narrow blood veins.


Photo

Post has attachment
Gastrointestinal / GI Stent Market worth 452.6 Million USD by 2022

https://www.marketsandmarkets.com/PressReleases/gastrointestinal-gi-stent.asp
The report "Gastrointestinal / GI Stent Market by Type (Biliary, Esophageal, Colonic, Pancreatic Stent) Material (Nitinol, Stainless Steel, Plastic) Disease (Biliary Disease, GI Cancer, IBD), End User (Hospital, Ambulatory Surgery Center) - Global Forecast to 2022", The global gastrointestinal stent market is projected to reach USD 452.6 Million by 2022 from USD 353.4 Million in 2017, at a CAGR of 5.1% during the forecast period. The increasing preference for minimally invasive surgeries and rising prevalence of GI cancers and other digestive diseases are the major factors driving the growth of the gastrointestinal stent market. The base year considered for the study is 2016, while, the forecast period is 2017 to 2022.
Browse 177 market data Tables and 32 Figures spread through 182 Pages and in-depth TOC on "Gastrointestinal / GI Stent Market by Type (Biliary, Esophageal, Colonic, Pancreatic Stent) Material (Nitinol, Stainless Steel, Plastic) Disease (Biliary Disease, GI Cancer, IBD), End User (Hospital, Ambulatory Surgery Center) - Global Forecast to 2022"
https://www.marketsandmarkets.com/Market-Reports/gastrointestinal-gi-stent-market-167758126.html
Early buyers will receive 10% customization on reports.
“By product, the biliary stent segment accounted for the largest share of the gastrointestinal stent market in 2016.”
On the basis of product, the biliary stent segment accounted for the largest share of the global gastrointestinal stent market. This can be attributed to the high prevalence of pancreatic cancer and biliary diseases as well as growth in the number of surgical procedures for the treatment of these diseases.
“By disease type, the biliary diseases segment held the largest market share of the gastrointestinal stent market in 2016.”
On the basis of disease type, the biliary diseases segment accounted for the largest share of the gastrointestinal stent market. The large share of this segment is attributed to the high prevalence of gastrointestinal diseases in the elderly population.
“The ambulatory surgery centers segment is expected to witness the highest growth rate in the gastrointestinal stent market, by end user, during the forecast period.”
Based on end user, the ambulatory surgery centers segment is expected to register the highest CAGR during the forecast period. Scheduling delays for operation, slow operating room turnover times, and the need for increasing the number of operating rooms in hospitals are the major factors supporting the growth of ASCs.
“North America dominated the gastrointestinal stent market in 2016.”
North America accounted for the largest share of the gastrointestinal stent market in 2016, followed by Europe and Asia Pacific. The developed healthcare system, rising geriatric population, and high prevalence of gastrointestinal cancers are the major factors responsible for the large share of North America in the gastrointestinal stent market.
The prominent players in the global gastrointestinal stent market are Boston Scientific (US), Cook Group (US), C.R. Bard (US), ELLA-CS (Czech Republic), Becton, Dickinson and Company (US), Merit Medical Systems (US), CONMED (US), Cantel Medical (US), Olympus (Japan), Taewoong Medical (South Korea), Micro-Tech (Nanjing) (China), Endo-Flex (Germany), and M.I. Tech (South Korea).

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=167758126

Post has attachment
Wait while more posts are being loaded